Start of a bull run on Heron Therapeutics.
Initial catalyst: PDUFA review of Cinvanti 11 November 2017
Secondary catalyst: Fast track designation for HTX-011
Initial catalyst: PDUFA review of Cinvanti 11 November 2017
Secondary catalyst: Fast track designation for HTX-011